Tactile Systems Technology is a medical device company headquartered in Minneapolis focused on at-home treatment of edema and vascular disease. Its core product, the Flexitouch® system, is a programmable pneumatic compression device with U.S. FDA 510(k) clearance for lymphedema and chronic wounds. The company serves tens of thousands of patients across the U.S. and addresses a condition that affects more than one million people annually in the U.S. The recent financing is intended to fund acquisition of a leading new product and intellectual property rights for additional lymphedema technology; the acquired technology already has 510(k) clearance and an assigned Medicare reimbursement code. Tactile says the new technologies will allow it to update solutions, strengthen its core business, fill gaps in current markets and expand into at-home treatments for other vascular diseases and chronic wound care. Management plans to use the proceeds to augment the existing product line, including the Flexitouch system, and advance the standard of care for chronic diseases at home.

Total raised

$10M

Funding rounds

1

Latest round

Series B

Latest activity

Oct 2012